Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “infiltrating”

85 pharma patents match "infiltrating" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 85
Index total 30,257
Page 1 / 4

Quick answer

This filtered view shows 85 pharmaceutical patents matching "infiltrating" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

85 results for “infiltrating” · 30,257 patents in full index Clear search

  1. US 12280140

    Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  2. US 12233075

    Remnant tumor infiltrating lymphocytes and methods of preparing and using the same

    Iovance Biotherapeutics, Inc. · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  3. US 12226434

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  4. US 12194061

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  5. US 12188048

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted
  6. US 12121541

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Oct 22, 2024 · Expires Oct 17, 2044

    granted
  7. US 12031157

    Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  8. US 12024718

    Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jul 2, 2024 · Expires Jun 27, 2044

    granted
  9. US 11998568

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  10. US 11975028

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted May 7, 2024 · Expires May 2, 2044

    granted
  11. US 11969444

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  12. US 11939596

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  13. US 11866688

    Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  14. US 11865140

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  15. US 11857573

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  16. US 11819517

    Methods of using tumor infiltrating lymphocytes in double-refractory melanoma

    Iovance Biotherapeutics, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  17. US 11667890

    Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion

    Iovance Biotherapeutics, Inc. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  18. US 11541077

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  19. US 11529372

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  20. US 11517592

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted
  21. US 11433097

    Methods of using tumor infiltrating lymphocytes in double-refractory melanoma

    Iovance Biotherapeutics, Inc. · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  22. US 11401503

    Methods of growing tumor infiltrating lymphocytes in gas-permeable containers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  23. US 11401506

    Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy

    Board nf Regents The Inivercitvof Texas Cvctom · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  24. US 11401507

    Remnant tumor infiltrating lymphocytes and methods of preparing and using the same

    Iovance Biotherapeutics, Inc. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted